CYP51 is an essential drug target for the treatment of primary amebic meningoencephalitis (PAM)

William Nes, C M Calvet, G Jennings, W. Zhou, A Aksenov, M R Luth, R Abagyn, William David Nes, J H Mckerrow, Larissa M Podust

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)e0006104
JournalPlos Neglected Tropical Disease
StatePublished - Dec 15 2017

Fingerprint Dive into the research topics of 'CYP51 is an essential drug target for the treatment of primary amebic meningoencephalitis (PAM)'. Together they form a unique fingerprint.

  • Cite this

    Nes, W., Calvet, C. M., Jennings, G., Zhou, W., Aksenov, A., Luth, M. R., Abagyn, R., Nes, W. D., Mckerrow, J. H., & Podust, L. M. (2017). CYP51 is an essential drug target for the treatment of primary amebic meningoencephalitis (PAM). Plos Neglected Tropical Disease, e0006104.